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Pulse-oximetry screening for the detection of congenital
heart defects is one of the most recent additions to the
recommended newborn-screening panel in the United
States. The idea behind the screen is quite simple: Pulse
oximetry detects hypoxemia in babies who have a mal-
formed heart and who are not yet visibly cyanotic (pulse
oximetry can also detect hypoxemia due to other reasons
for that matter). This early detection will hopefully
improve prognosis by facilitating early interventions, but
we don’t have full measures of the ability of this screen
to identify the babies who need these interventions. This
has led to a recent meta-analysis by Thangaratinam et al.,
who compiled screening data from more than 200,000
asymptomatic newborns with the aim of establishing the
sensitivity and specificity of pulse-oximetry screening for
heart defects. This screen identified more than three-
quarters of the babies with critical congenital heart defects
and had a false-positive rate that was quite low and that
could be further reduced when screening occurred after
24 hours of life. These data could be used to guide policy
development for the implementation of this screen in
the United States, which is the first country for which
this screening has been recommended.
Thangaratinam et al. (2012). The Lancet. Published online
May 1, 2012. 10.1016/S0140-6736(12)60107-X.
Test-Tube Tracking
The world’s first test-tube baby, Louise Brown, has a family
of her own at this point, so it would seem that after more
than 20 years of experience with assisted reproduction, we
would fully understand its risks or lack thereof. In the
United States, particularly, fertility clinics are not heavily
regulated or monitored, making it difficult to study
outcomes in babies born via these procedures. A recent
study by Davies et al. linked various registry data in South
Australia so that diagnoses of birth defects up to the age of
5 years could be linked back to birth data and to the use of
assisted reproduction technologies (ART). This large
cohort study allowed Davies et al. to compare birth defects
among babies who were born after the use of ART with
either fresh or frozen embryos, and it also allowed compar-
ison of different techniques. After adjustment for parental
factors, the risk of birth defects in babies born after in vitro
fertilization was not different than the risk in spontane-
ously conceived babies. However, the risk was increased1Department of Human Genetics, Emory University School of Medicine, Atlan
*Correspondence: kgarber@genetics.emory.edu
DOI 10.1016/j.ajhg.2012.05.014. 2012 by The American Society of Human
The Amin babies born after intracytoplasmic sperm injection
(ICSI), confirming previous results. Attributing all of this
risk simply to ICSI is not as straightforward as you might
think; the risk of birth defects is also increased in women
with a history of infertility regardless of the use of ART.
The increased risks of birth defects in this study are
probably not large enough to deter many couples from
pursuing ART; on the other hand, understanding ART-
associated risks could lead to improvements of these
techniques.
Davies et al. (2012). N Engl J Med. 366, 1803–1813.
Signature of the Human Population Boom
It appears as though the human population size increased
at a slow and steady pace until we figured out how to
cultivate crops and herd animals. Thousands of years
ago, there wasn’t a way to take a global census, but histor-
ical human population growth can be estimated on the
basis of population genetic variation. Several groups
have used this variation to model human population
dynamics but have produced discrepant results. Keinan
and Clark got to thinking that the larger the sample size
used in these studies, the rarer the genetic variation that
can be ascertained. Because the youngest genetic variation
in the population should be the rarest, the sample size
could thus drastically influence the outcome of these
studies, particularly given the fact that over historically
recent times, the rate of human population growth has
increased dramatically to the exponential growth that
we see today. On the basis of this idea, they asked how
different models of human population history influence
the site frequency spectrum and how the sample size
used for the assessment of this spectrum influences the
results. Their simulations suggest that exponential popu-
lation growth leads to a large excess of rare genetic varia-
tion that can only be appreciated in very large sample
sizes. This excess rare variation must be taken into
account as rare variation is explored for its contribution
to complex disease.
Keinan et al. (2012). Science 336, 740–743.
Aging and Acquired Mosaicism
Genetic mosaicism, which denotes the presence of more
than one genetically distinct population of cells in an indi-
vidual, has been described in association with abnormal
outcomes. Presumably, somatic mosaicism occurs inta, GA 30322, USA
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many of us, but because genetic analyses are much less
likely to be indicated in apparently normal individuals,
good measures of the frequency of mosaicism in the
general population are unavailable. Two recent papers
have made use of the large datasets that were amassed
for genome-wide association studies in order to assess
somatic mosaicism in samples of thousands of individuals.
Both studies analyzed available genome-wide SNP array
data and found a strong association between somatic
mosaicism and age; this association ultimately means
that ~2% of elderly individuals exhibit mosaicism, which
includes copy-number gains and losses as well as copy-
neutral loss of heterozygosity. Is this mosaicism of any
consequence? Both studies suggest that, in fact, it is. Laurie
et al. estimate that the risk of hematologic cancer is ten
times higher for mosaic individuals than for nonmosaic
individuals and propose that this mosaicism might be an
asymptomatic condition that predisposes to hematolog-
ical cancers. Jacobs et al. describe an association with non-
hematologic cancers and report that the frequency of
mosaic events decreases with treatment. How this age-
related mosaicism arises is still unclear; it might, for
example, result from an increased mutation rate or from
the expansion of an already-existing clone to a detectable
level.
Jacobs et al. (2012). Nat Genet. Published online May 6,
2012. 10.1038/ng.2270.
Laurie et al. (2012). Nat Genet. Published online May 6,
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Recombination isn’t just a way to shuffle genetic material
during sexual reproduction; it is essential for the proper
segregation of chromosomes during meiosis. It makes
sense, then, that the location of recombination isn’t
simply left to chance. After all, this shuffling generally
has to churn out something selectively advantageous
rather than muck up essential genes. Enter PRDM9,
a histone H3 methyltransferase that has recently been
found to control recombination hotspots. Brick et al.
recently discovered that not only does it determine where
hotspots occur, but it also steers these sites away from func-
tional genetic elements. The authors analyzed recombina-
tion in mice with various Prdm9 alleles and found that
recombination hotspots occur at strain-specific histone
H3 lysine 4 trimethylation (H3K4me3) marks, and the hot-
spots differ depending on the Prdm9 allele present. Prdm9
isn’t required for recombination but rather shifts the loca-
tion of hotspots; in the absence of Prdm9, these hotspots
are still found at H3K4me3 marks, but they preferentially
occur at H3K4me3 marks neighboring transcription start
sites, which are rarely used for recombination in wild-
type mice. The authors propose that H3K4me3 provides
the right environment for recombination and that
Prdm9 limits the potential for this genetic shuffle to intro-
duce intragenic mutations by recruiting the recombina-
tion machinery away from functional elements.
Brick et al. (2012). Nature. Published online May 13, 2012.
10.1038/nature11089.This Month in Our Sister JournalsMultiple Roles for APP in Worms
Despite the facts that we have known for quite some time
that deposition of the Ab fragment of the amyloid
precursor protein (APP) plays an important role in Alz-
heimer disease and that we know that there are rare
families with early-onset Alzheimer disease due to muta-
tions in APP, the actual physiological role of APP is not
well understood. Unlike mammalian species, C. elegans
has a single APP-related protein, so Ewald et al. reasoned
that C. elegans would be a good model in which to study
the function of these proteins. This C. elegans gene, apl-1,
is essential for viability. When Ewald et al. further teasedthis apart by using a combination of mutants, they found
that apl-1 is required for developmental timing and for
the molt at each larval transition. On the basis of the
genetic interactions that they uncovered in their experi-
ments, the authors tie APL-1 to insulin signaling and
other pathways that ultimately affect the process of
development as well as metabolic functions. This work
raises the question as to the role of human APP in metab-
olism and whether this function is altered in Alzheimer
disease.
Ewald et al. (2012). Genetics. Published online March 30,
2012. 10.1534/genetics.112.138768.012
